Thermo Fisher Scientific talks qPCR, digital PCR, NGS for infectious diseases at AMP 2022

Leo O'Connor
Nov 17, 2022
Latest in Business Insights
Dna Data Ai Social
MiLaboratories raises $10M in series A funding, launches NGS software platform
October 11, 2024
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Lab Tubes Pipette Social
CAP, ADLM, NILA caution court in FDA LDT decisions
October 9, 2024
Influenza B virus particles, colorized blue, via National Institute of Allergy and Infectious Diseases (NIAID).
FDA greenlights first non-EUA at-home flu and COVID-19 test
October 8, 2024
Related Stories
Hands Shaking Deal
Mergers & Acquisitions
Thermo Fisher Scientific, Heska complete previously announced acquisitions
3 D Monkeypox Infecting Cell Social
PCR
Thermo Fisher Scientific obtains FDA EUA for monkeypox/orthopox virus DNA kit
Sequencing Dna Rna Social
Cancer
AMP assesses clinical implementation of past standards, guidelines for sequence variants in cancer
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Business Insights
MiLaboratories raises $10M in series A funding, launches NGS software platform
By LabPulse.com staff writers
Bioinformatics firm MiLaboratories closed a $10 million series A funding round alongside the launch of its Platforma.bio Software Development Kit.
October 11, 2024
Dna Data Ai Social
NowDiagnostics at-home syphilis test gets boost from Labcorp agreement
By LabPulse.com staff writers
STI National Strategic Plan aims to reverse recent rise of STIs.
October 10, 2024
Syphilis Treponema Bacteria Social
CAP, ADLM, NILA caution court in FDA LDT decisions
By Liz Carey
Organizations rally on deadline for amicus briefs.
October 9, 2024
Lab Tubes Pipette Social
FDA greenlights first non-EUA at-home flu and COVID-19 test
By LabPulse.com staff writers
Healgen Scientific's test targets proteins from both SARS-CoV-2 and flu A and B, plus updated FDA test listings.
October 8, 2024
Influenza B virus particles, colorized blue, via National Institute of Allergy and Infectious Diseases (NIAID).
Exact Sciences gets FDA approval for next-gen Cologuard Plus test
By LabPulse.com staff writers
Exact Sciences has received U.S. Food and Drug Administration (FDA) approval for its next-generation Cologuard Plus colorectal cancer (CRC) screening test.
October 7, 2024
Fda Sign Dc Social
WHO approves Abbott mpox test for emergency use
By LabPulse.com staff writers
The World Health Organization (WHO) authorized Abbott Laboratories' mpox diagnostic test under its emergency use listing procedure, the first such approval by the agency in its effort to expand the diagnostic capacity of countries facing mpox outbreaks.
October 4, 2024
3 D Monkeypox Infecting Cell Social
Healthcare service mobilization shows challenges after Helene
By Liz Carey
While CMS is accelerating payments, the efforts involved in running healthcare facilities are 'astounding.' Competing priorities will impact recovery, disaster researcher says in video interview.
October 4, 2024
Noaa Satellite Image September26272024
Codexis, Alphazyme forge licensing agreement for genomics enzymes
By LabPulse.com staff writers
Enzyme engineering firm Codexis has entered into a commercial and manufacturing license agreement with Alphazyme for multiple enzymes from Codexis' life science enzyme portfolio.
October 3, 2024
Hands Shaking Deal Social
Proscia launches pathology AI model toolkit
By Liz Carey
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
October 2, 2024
Proscia Embeddings
CRISPR patent decisions could trigger waves globally
By LabPulse.com staff writers
Canceling a pair of patents in Europe will affect a broad network of biotech companies that have bought and sold the rights to pursue gene-slicing research, according to a September 25 report published in MIT Technology Review.
September 30, 2024
Crispr Cas9 Gene Editing
Lagging claims payment disputes with providers to cost Anthem $8.5M
By LabPulse.com staff writers
The California Department of Managed Health Care has fined Anthem Blue Cross $8.5 million for failing to address claims payment disputes in a timely manner from doctors, hospitals, and other healthcare providers.
October 1, 2024
Claim Denied Form
Qiagen launches clinical oncology testing system
By LabPulse.com staff writers
Qiagen has expanded its digital polymerase chain reaction portfolio and plans to enter the clinical testing space in North America and the European Union.
October 1, 2024
Test Tubes Social (2)
Page 1 of 191
Next Page